- Trials with a EudraCT protocol (170)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
170 result(s) found for: Nk Cells.
Displaying page 1 of 9.
EudraCT Number: 2012-000411-91 | Sponsor Protocol Number: NKZellen-Version1.0 | Start Date*: 2013-02-13 |
Sponsor Name:Charité - Universitätsmedizin Berlin | ||
Full Title: Monitoring natural killer cells in multiple sclerosis patients treated with fingolimod: a monocentric, prospective, one year, baseline-to-treatment, open-label, single group pilot trial | ||
Medical condition: relapsing-remitting multiple sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002077-35 | Sponsor Protocol Number: EC-HEM-HGUGM-2016-01 | Start Date*: 2017-05-05 |
Sponsor Name:José Luís Díez Martín | ||
Full Title: CLINICAL TRIAL PHASE I / II, SINGLE-CENTER, HISTORICAL CONTROL, TO EVALUATE THE EFFECTIVENESS OF DONOR IL-15-STIMULATED NK CELLS POST TRANSPLANT INFUSION, IN ACUTE LEUKEMIA PATIENTS WITH POOR PROGN... | ||
Medical condition: High risk acute myeloid leukemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001514-34 | Sponsor Protocol Number: ILNK15-01 | Start Date*: 2012-04-03 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Infusion of IL-15 activated NK cells after allogeneic stem cell transplantation in children transplanted for relapsed/refractory leukemia: a feasibility study | |||||||||||||
Medical condition: Children with high-risk and recurrent acute leukemia are eligible for allogeneic hematopoietic stem cell transplantation (HSCT). However, leukemia relapse and viral infections after HSCT remain mai... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000054-63 | Sponsor Protocol Number: HNJ-NKAES-2012 | Start Date*: 2012-07-25 |
Sponsor Name:FUNDACION INVESTIGACION BIOMEDICA HOSPITAL NINO JESUS | ||
Full Title: Salvage therapy with chemotherapy and Natural Killer cells in relapsed/refractory paediatric T cell lymphoblastic leukaemia and lymphoma. | ||
Medical condition: Relapsed/refractory paediatric T cell lymphoblastic leukaemia and lymphoma. | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001929-27 | Sponsor Protocol Number: NK4AML | Start Date*: 2020-05-20 |
Sponsor Name:Radboud University Medical Centre | ||
Full Title: Infusion of ex vivo-generated allogeneic natural killer cells in combination with subcutaneous IL-2 in patients with acute myeloid leukemia: a phase I/IIa study’ | ||
Medical condition: AML patients who do not have rapid progressive disease with or without disease controlling medication and who are not eligible for allogeneic SCT. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005146-38 | Sponsor Protocol Number: LANK-2 | Start Date*: 2013-03-13 | |||||||||||
Sponsor Name:ANTONIO PEREZ MARTINEZ | |||||||||||||
Full Title: "LANK-2": activated and expanded NK cell immunotherapy together with salvage chemotherapy in children, adolescents and young adults with relapsed or refractary acute leukemia | |||||||||||||
Medical condition: Relapsed/refractory acute leukaemia | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003421-28 | Sponsor Protocol Number: TUD-HINKL1-059 | Start Date*: 2014-07-10 | |||||||||||
Sponsor Name:Technische Universität Dreden | |||||||||||||
Full Title: Randomised controlled phase-2 trial to determine the efficacy of adoptive immunotherapy with haploidentical natural killer cells in high-risk acute myeloid leukemia | |||||||||||||
Medical condition: Newly diagnosed high-risk AML other than acute promyelocytic leukemia, ≥20% blasts | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003578-42 | Sponsor Protocol Number: SANKOMA_2016 | Start Date*: 2018-04-25 | |||||||||||
Sponsor Name:Antonio Pérez-Martínez | |||||||||||||
Full Title: Phase I / II Clinical Trial, multicenter, open, of infusion of activated NK cells for the treatment of children, adolescents and young adults with sarcomas. | |||||||||||||
Medical condition: Sarcoma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2023-000061-14 | Sponsor Protocol Number: BCN04-DASA | Start Date*: 2023-05-26 | |||||||||||
Sponsor Name:Institut de Recerca Germans Trias i Pujol | |||||||||||||
Full Title: Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People with HIV under Antiretroviral Treatment | |||||||||||||
Medical condition: Human immunodeficiency virus (HIV) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001901-15 | Sponsor Protocol Number: NKCell_LMA_2015 | Start Date*: 2016-04-01 | |||||||||||
Sponsor Name:Antonio Pérez Martínez | |||||||||||||
Full Title: Natural Killer cell infusion as consolidation therapy in children and adolescents with acute myelogenous leukemia. | |||||||||||||
Medical condition: Acute myeloid leukemia | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005634-59 | Sponsor Protocol Number: TEA-001 | Start Date*: 2015-04-29 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Toll-like receptor 9 enhancement of antiviral immunity in chronic HIV-1 infection: a phase 1b/2a trial (TEACH) | |||||||||||||
Medical condition: HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002234-53 | Sponsor Protocol Number: eCLEAR-001 | Start Date*: 2016-11-14 | |||||||||||
Sponsor Name:Department of Infectious Diseases, Aarhus University Hospital | |||||||||||||
Full Title: Early administration of anti-latency reversing therapy and broadly neutralizing antibodies to limit the establishment of the HIV-1 reservoir during initiation of antiretroviral treatment - a random... | |||||||||||||
Medical condition: HIV persistence during initiation of antiretroviral therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005419-18 | Sponsor Protocol Number: 01INMUNOGEST14 | Start Date*: 2016-07-01 | |||||||||||
Sponsor Name:silvia sanchez ramon | |||||||||||||
Full Title: CLINICAL TRIAL, PHASE III, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED WITH INTRAVENOUS IMMUNOGLOBULIN HUMAN FOR THE TREATMENT OF REPEAT ABORTION WITH IMMUNE ETIOLOGY | |||||||||||||
Medical condition: recurrent aborption with inmunological etiology | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003181-32 | Sponsor Protocol Number: CIMNK1001 | Start Date*: 2011-10-14 | ||||||||||||||||
Sponsor Name:Karolinska University Hospital | ||||||||||||||||||
Full Title: In vivo expansion and efficacy of adoptive natural killer cell-based immunotherapy for high-risk myeloid diseases | ||||||||||||||||||
Medical condition: acute myeloid leukemia and myelodysplastic syndrome | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-002991-42 | Sponsor Protocol Number: HCV-13-01 | Start Date*: 2013-12-19 |
Sponsor Name:Foundation for Liver Research | ||
Full Title: Effect of ASV and DCV therapy on the quality of immune status in chronic HCV patients Investigator initiated research proposal nr. AI447-108 | ||
Medical condition: Chronic hepatitis C | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-002130-30 | Sponsor Protocol Number: NSCLC-TKD/IL-2 | Start Date*: 2013-11-15 | |||||||||||
Sponsor Name:Technische Universität München Fakultät für Medizin | |||||||||||||
Full Title: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with Non-Small Cell Lung Cancer (NSCLC) after radiochemotherapy (RCT) | |||||||||||||
Medical condition: Interventional phase II clinical trial incorporating a parallel control group of patients receiving no adjuvant immunotherapy. Patients with non small lung cell carcinoma (NSCLC) in stage III A and... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007446-54 | Sponsor Protocol Number: HBV99-03 | Start Date*: 2009-03-26 | |||||||||||
Sponsor Name:Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam | |||||||||||||
Full Title: LOWERING VIRAL LOAD WITH NUCLEOS(T)IDE ANALOGUES PRIOR TO PEG-INTERFERON ALFA-2B TREATMENT TO INCREASE SUSTAINED RESPONSE IN HBEAG-POSITIVE CHRONIC HEPATITIS B (PADD-STUDY) | |||||||||||||
Medical condition: Chronic hepatitis B virus infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022066-28 | Sponsor Protocol Number: CFTY720DDE01 | Start Date*: 2011-01-18 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A 6-month multicenter, single-arm, open-label study to investigate changes in biomarkers after initiation of treatment with 0.5 mg fingolimod (FTY720) in patients with relapsing-remitting multiple ... | |||||||||||||
Medical condition: relapsing remitting Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000545-40 | Sponsor Protocol Number: FELZ01 | Start Date*: 2021-08-01 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Safety, Tolerability and Efficacy of Monoclonal CD38 Antibody Felzartamab in Late Antibody-Mediated Renal Allograft Rejection – A Phase 2 Pilot Trial | ||
Medical condition: Late active or chronic active antibody-mediated rejection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004557-24 | Sponsor Protocol Number: UKM17_0056 | Start Date*: 2019-07-29 | |||||||||||
Sponsor Name:Westfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u. Drittmittel | |||||||||||||
Full Title: Clarifying the mechanism of action of cladribine in relapsing multiple sclerosis | |||||||||||||
Medical condition: Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Temporarily Halted) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.